Terms: = Sarcomas AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
56 results:
1. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
2. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract] [Full Text] [Related]
3. Colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype.
Golconda U; McHugh KE; Allende DS; Collins K; Henn P; Lacambra M; Bejarano PA; Groisman GM; Loughrey MB; Monappa V; Zhang X; Hornick JL; Gonzalez RS
Am J Surg Pathol; 2024 Apr; 48(4):465-474. PubMed ID: 38155543
[TBL] [Abstract] [Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
5. [The expression of neuraminidase-1 in Ewing sarcoma and its impact on sarcoma cell proliferation and migration].
Liu BF; Gao YZ
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3287-3293. PubMed ID: 37926573
[No Abstract] [Full Text] [Related]
6. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
[TBL] [Abstract] [Full Text] [Related]
7. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
8. Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study.
Wang J; Li M; Guo P; He D
J Orthop Surg Res; 2023 Jun; 18(1):465. PubMed ID: 37370182
[TBL] [Abstract] [Full Text] [Related]
9. Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in Gastric Tumors from Latinos.
Toal TW; Estrada-Florez AP; Polanco-Echeverry GM; Sahasrabudhe RM; Lott PC; Suarez-Olaya JJ; Guevara-Tique AA; Rocha S; Morales-Arana A; Castro-Valencia F; Urayama S; Kirane A; Wei D; Rios-Sarabia N; Medrano R; Mantilla A; Echeverry de Polanco M; Torres J; Bohorquez-Lozano ME; Carvajal-Carmona LG
Cancer Res Commun; 2022 Nov; 2(11):1487-1496. PubMed ID: 36970058
[TBL] [Abstract] [Full Text] [Related]
10. Studies related to osteosarcoma and metabolism from 1990 to 2022: A visual analysis and bibliometric study.
Shao Z; Bi S
Front Endocrinol (Lausanne); 2023; 14():1144747. PubMed ID: 36950694
[TBL] [Abstract] [Full Text] [Related]
11. Trends in incidence, survival and initial treatments of gynecological sarcoma: a retrospective analysis of the United States subpopulation.
He X; Dong Q; Weng C; Gu J; Yang Q; Yang G
BMC Womens Health; 2023 Jan; 23(1):10. PubMed ID: 36624439
[TBL] [Abstract] [Full Text] [Related]
12. Epidemiology and prediction model of patients with carcinosarcoma in the United States.
Chen M; He X; Yang Q; Zhang J; Peng J; Wang D; Tong K; Huang W
Front Public Health; 2022; 10():1038211. PubMed ID: 36518582
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of prognostic factors of undifferentiated pleomorphic sarcoma and construction and validation of a prediction nomogram based on SEER database.
Wang Z; Liu J; Han J; Yang Z; Wang Q
Eur J Med Res; 2022 Sep; 27(1):179. PubMed ID: 36109828
[TBL] [Abstract] [Full Text] [Related]
14. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract] [Full Text] [Related]
15. Development of an Accessible Gene Expression Bioinformatics Pipeline to Study Driver Mutations of Colorectal Cancer.
van den Driest L; Johnson CH; Rattray NJW; Rattray Z
Altern Lab Anim; 2022 Jul; 50(4):282-292. PubMed ID: 35765262
[TBL] [Abstract] [Full Text] [Related]
16. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract] [Full Text] [Related]
17. The incidence, treatment and survival of patients with rare types of rectal malignancies in the Netherlands: A population-based study between 1989 and 2018.
van Rees JM; Elferink MAG; Tanis PJ; de Wilt JHW; Burger JWA; Verhoef C
Eur J Cancer; 2021 Jul; 152():183-192. PubMed ID: 34118528
[TBL] [Abstract] [Full Text] [Related]
18. Incidence, prognostic significance, and survival outcomes of primary cardiac sarcoma: An updated population-based retrospective study.
Hammami MB; Al-Wawi MZ; Fazel H; Oudih M
Anatol J Cardiol; 2021 Feb; 25(2):104-110. PubMed ID: 33583817
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract] [Full Text] [Related]
20. miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.
Molist C; Navarro N; Giralt I; Zarzosa P; Gallo-Oller G; Pons G; Magdaleno A; Moreno L; Guillén G; Hladun R; Garrido M; Soriano A; Segura MF; Sánchez de Toledo J; Gallego S; Roma J
Cancer Lett; 2020 May; 477():49-59. PubMed ID: 32142919
[TBL] [Abstract] [Full Text] [Related]
[Next]
